Last year, the group of Benedikt Kessler published a similar strategy to map ISG15 modification sites in the chronic myeloid leukemia (CML)-derived cell line HAP1 (57). This evidence concerns the gene ISG15 and chronic myelogenous leukemia, BCR-ABL1 positive.